Found 14 matching trials
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
PHASE3This study evaluates the safety and efficacy of once-daily application of C...
Location
Multiple Locations
Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis
PHASE2This study has a randomized, double-blind, placebo-controlled design to ass...
Location
LUMC/Centre for Human Drug Research
Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN
PHASE2To assess the pharmacodynamics, safety/tolerability and efficacy of topical...
Location
LUMC/Centre for Human Drug Research
Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts
PHASE2The purpose of this study is to assess the pharmacodynamics, safety and eff...
Location
LUMC/Centre for Human Drug Research
A Twelve Week Safety and Efficacy Study in Rosacea
PHASE2The purpose of this study is to evaluate th safety and efficacy of one-dail...
Location
Radiant Research Inc.
Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel
PHASE3This study evaluates the long-term safety of once-daily application of Omig...
Location
Multiple Locations
Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis
PHASE2To explore the efficacy and pharmacodynamic effects of omiganan topical gel...
Location
Centre for Human Drug Research
Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections
PHASE3Central venous catheters (CVCs) are used in patient care for such purposes ...
Location
Omnicare Clinical Research Inc.
Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis
PHASE2To assess the pharmacodynamics, safety/tolerability, and efficacy of omigan...
Location
Centre for Human Drug Research
Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects
PHASE3The purpose of this research study is to determine if omiganan 1% gel (the ...